Background: Surgical clipping or endovascular coiling are the main
aneurysms between January 2010 and December 2015. The overall cost of hospitalization was assessed by using the micro-costing technique. The calculation was based on the tariffs of medical procedures as defined by the Ministry of Health in Morocco. A regression analysis was used to define the correlation between the overall cost and the various parameters. Results: Univariate linear regression showed that the total cost was influenced by overall duration of hospitalization, ICU duration of hospitalization and size of aneurysm. On the other hand, univariate linear regression showed that the total cost was not influenced by sex, localization of aneurysm, and size of the aneurysm's neck. However, multivariate linear regression showed that the total cost was influenced by one type of insurance health, overall duration of hospitalization, ICU duration of hospitalization, size of the aneurysm, and size of the aneurysm's neck.
Conclusion:
Setting a rate for reimbursement of patients who have had coiling treatment for a cerebral aneurysm should take into account the results of our study in order to limit the costs borne by patients. The parameters that influence the overall cost must be reimbursed in each case while the parameters that do not influence treatment costs could be included in a lump sum. The ISAT is the first multicenter prospective randomized trial comparing endovascular treatment and surgery [8] . A total of 2,143 patients with ruptured intracranial aneurysms were randomly assigned to clipping (n = 1070) or coiling (n = 1073). The ISAT trial demonstrated that in patients with ruptured intracranial aneurysms suitable for both treatments, endovascular coiling is more likely to result in independent survival at 1 year than neurosurgical clipping; this survival benefit continues for at least 7 years. The risk of late rebleeding is low, but is more common after endovascular coiling than after neurosurgical clipping [9] .
New and innovative procedures, such as cerebral aneurysm coiling, can be associated with significant cost and will be in the spotlight 
RESULTS
A description of the clinical parameters of the patients in our study is presented in Table 1 below.
In total, 124 aneurysms in 117 patients were treated. The mean age of the patients was 51.2 ± 14 years. Fifty-one (43.6 %) patients were men and 66 (56.4 %) were women. The sex ratio was M/F = 0.43. Seventy (60 %) patients were covered by health insurance. The median overall stay was 7 days (range 4-11), 1 day in the ICU (1-2) and 5 days in medical units (2.5-9).
The overall average cost of treatment was 9606.0 €, varying from 3,702.3 € to 32,172.3 €.
Pharmaceutical products represent 55 % of the overall cost (70 % for medical devices and 30 % for drugs) and the average was 5280.5 € with a range of 2087.4 €-19,526.2 €.
Univariate linear regression showed that the total cost was influenced by overall duration of hospitalization, ICU duration of hospitalization, size of aneurysm. On the other hand, univariate linear regression showed that the total cost was not influenced by sex, localization of the aneurysm, and size of aneurysm's neck (Table 2) .
However, multivariate linear regression showed that the total cost was influenced by Johnston et al. concluded that total length of stay was longer (mean 7 days for surgical patients vs. 5 days for endovascular patients) and hospital charges were greater for surgical clipping (US$ 38,000 for surgical patients vs. US$33,400 for endovascular patients) [20] . Duan et al.
(Cleveland, OH, USA) concluded that morbidity and length of stay for patients treated with clipping was greater. Total hospital costs and variable direct costs for clipping were significantly lower than for coiling (p = 0.003, p\0.001, respectively). Fixed direct costs and fixed indirect costs for clipping were higher than for coiling (p\0.001, p\0.001, respectively).
Variable direct costs comprised 50.5 % and 68.6 % of total hospital costs for clipping and coiling, respectively (p\0.001) [21] .
Lad et al., however, concluded that although the surgical clipping resulted in lower reoperation rates, it was associated with higher complication rates and initial costs. However, overall costs at 2 and 5 years were similar to endovascular coiling due to the significantly higher number of follow-up angiograms and outpatient costs in these patients [22] . 
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Similarly, some observational studies of patients with unruptured intracranial aneurysms show that discharge outcomes were better and hospital costs were lower after endovascular treatment than after surgery.
These patients showed no difference between the two treatments in 1-year outcomes and later rebleeding, although few data were available for this comparison [19, 23] .
We performed this comparative study at Cheikh Zaid hospital in Rabat and we found similar results compared to the studies cited above. Ninety patients were treated by embolization and 13 patients by neurosurgery. The median overall length of stay was greater in patients treated by neurosurgery (13 vs. 8 days, respectively). By contrast, the median cost of pharmaceutical products was more signifcant for embolization than for neurosurgery (4,000 € vs. 1,570 €, respectively). This difference was offset by the cost of hospitalization which was far more for patients treated with neurosurgery. The difference in the average overall cost between the two groups was not significant (p = 0.39).
Furthermore, endovascular treatment can be a good option for the treatment of cerebral aneurysms in this context; it reduces the length of hospital stay, and therefore avoids the risk of complications or nosocomial infections. This will also allow the hospital to admit more patients. However, the high cost of pharmaceutical products used in such a procedure can impact heavily on the budget of the hospital.
Our series concluded that the cost of pharmaceutical products is one of the major handicaps of the development of this technique (the share of pharmaceutical product cost is 55 % of the overall cost), specifically coils, stents, balloons, micro-catheters, and guides. In Morocco, there is no regulation (pricing) of medical devices by the ministry of health [14] . The cost of medical devices is negotiated between hospitals and suppliers after validation by the committee on drugs and medical devices [14] . This is one of the factors contributing to the high cost of medical devices used in this technique. The fact that the cost of coils and other medical devices is the main contributor to the higher costs of coiling was also found in the study by Duan et al. [21] .
The second obstacle in improving this technique is the balance of fees paid by health insurance (5364 €), which is only 75 % of the average full cost calculated in this series. The remaining cost is borne by the patients. The results of our study show that it is very difficult to allocate a lump sum to this treatment because the overall cost of care depends on several parameters that cannot be standardized between patients. The results of our study also show that the overall cost of care is influenced by the total length of stay in hospital and the length of stay in the ICU. This result can be explained by the fact that if the number of patient days increased, specifically in the ICU, the overall cost of hospitalization becomes important and significantly affects the cost of global support.
In addition, there is a significant correlation between the global cost and the size of the aneurysm on the one hand and the size of the aneurysm's neck on the other. These results are logical because the larger the size of the aneurysm, the greater the number of coils.
Also, the number and type of devices used are related to the aneurysm's neck size; the neuroradiologist is forced to use a balloon dilatation or stent, which involves a significant increase in costs incurred.
Our study has some limitations, mainly relating to the lack of data on the cost of other services that the patient may have outside the hospital, the cost of other services provided post-embolization, and the amount actually reimbursed by the health funds for each patient.
CONCLUSION
The coiling technique is an effective modality for the treatment of intracranial aneurysms.
Unfortunately, this technique is expensive and not available to all patients, especially those not covered by a health insurance plan. In addition, the co-payment that patients covered by the compulsory health insurance scheme in Morocco have to bear is significant, as the package specified by the national health insurance agency and insurance funds remains below the actual value of the disease management.
Setting a rate for reimbursement of patients who have had coiling treatment of a cerebral aneurysm should take into account the results of our work in order to limit the amount borne by patients. The parameters that influence the overall cost must be reimbursed in each case while the parameters that do not influence treatment costs could be included in a package.
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